Answers are grounded in this paper and cite their sources.
The global mortality due to cryptococcosis caused by Cryptococcus neoformans or C. gattii is unacceptably high. Currently available therapies are decades old and may be impacted by drug resistance. Therefore, the need for more effective antifungal drugs for cryptococcosis is evident. A number of Cryptococcus virulence factors have been studied in detail, providing crucial information about the fungal biology and putative molecular targets for antifungals. This review focuses on the use of well-described virulence factors of Cryptococcus as potential anticryptococcal agents.
No takes yet. Share an insight, caveat, or question.
Azevedo et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: